EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Reversible electroporation for cancer therapy

Taha Shiwani iD, Simran Singh Dhesi, Tze Min Wah

British Journal of Radiology · 01.03.2025 · 98 (1167) · 313-320

DOI: 10.1093/bjr/tqae231 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Radiology, online erschienen am 23.11.2024. Verfasst von Taha Shiwani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Beckett St, Leeds, LS9 7T…. Hauptthemen laut MEDLINE: Electrochemotherapy, Neoplasms, Electroporation, Antineoplastic Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reversible electroporation (EP) refers to the use of high-voltage electrical pulses on tissues to increase cell membrane permeability. It allows targeted delivery of high concentrations of chemotherapeutic agents including cisplatin and bleomycin, a process known as electrochemotherapy (ECT). It can also be used to deliver toxic concentrations of calcium and gene therapies that stimulate an anti-tumour immune response. ECT was validated for palliative treatment of cutaneous tumours. Evidence to date shows a mean objective response rate of ∼80% in these patients. Regression of non-treated lesions has also been demonstrated, theorized to be from an in situ vaccination effect. Advances in electrode development have also allowed treatment of deep-seated metastatic lesions and primary tumours, with safety demonstrated in vivo. Calcium EP and combination immunotherapy or immunogene electrotransfer is also feasible, but research is limited. Adverse events of ECT are minimal; however, general anaesthesia is often necessary, and improvements in modelling capabilities and electrode design are required to enable sufficient electrical coverage. International collaboration between preclinical researchers, oncologists, and interventionalists is required to identify the most effective combination therapies, to optimize procedural factors, and to expand use, indications and assessment of reversible EP. Registries with standardized data collection methods may facilitate this.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ElectrochemotherapyNeoplasmsElectroporationAntineoplastic AgentsHumans

Stichwörter der Autor:innen

ablationcalciumelectrochemotherapyelectropermeabilisationelectroporationelectrotransferimmunotherapyinterventiononcologyreversible

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Radiology, St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Beckett St, Leeds, LS9 7TF, United Kingdom.

ORCID-Profile: Taha Shiwani

Zitieren

APA

Shiwani, T., Singh Dhesi, S., & Wah, T. M. (2025). Reversible electroporation for cancer therapy. British Journal of Radiology, 98(1167), 313-320. https://doi.org/10.1093/bjr/tqae231

Vancouver

Shiwani T, Singh Dhesi S, Wah TM. Reversible electroporation for cancer therapy. British Journal of Radiology. 2025;98(1167):313-320. doi:10.1093/bjr/tqae231

BibTeX
@article{Shiwani2025,
  author = {Shiwani, Taha and Singh Dhesi, Simran and Wah, Tze Min},
  title = {Reversible electroporation for cancer therapy},
  journal = {British Journal of Radiology},
  year = {2025},
  volume = {98},
  number = {1167},
  pages = {313--320},
  doi = {10.1093/bjr/tqae231}
}
Kostenlos starten →